Selected research
Industry Research
Beauty Peptide Industry Research Report 2026
Market perspective
The global Beauty Peptide market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Beauty Peptide is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Beauty Peptide is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Beauty Peptide is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Beauty Peptide include among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Beauty Peptide market in revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Beauty Peptide.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Beauty Peptide Market by Company
Readline Biotech
Pentapharm
Pentapharm
Lipotec
ISP
Helix BioMedix
Evonil
Atrium
Beauty Peptide Segment by Type
Signal Peptides
Neurotransmitter-Inhibiting Peptides
Carried Peptides
Beauty Peptide Segment by Application
Anti-ageing
Whitening
Others
Beauty Peptide Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Beauty Peptide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Beauty Peptide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Beauty Peptide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Beauty Peptide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Beauty Peptide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Beauty Peptide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Signal Peptides
- Neurotransmitter-Inhibiting Peptides
- Carried Peptides
Applications
- Anti-ageing
- Whitening
- Others
Companies covered
- Readline Biotech
- Pentapharm
- Pentapharm
- Lipotec
- ISP
- Helix BioMedix
- Evonil
- Atrium
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Beauty Peptide by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Signal Peptides
- 2.2.3 Neurotransmitter-Inhibiting Peptides
- 2.2.4 Carried Peptides
- 2.3 Beauty Peptide by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Anti-ageing
- 2.3.3 Whitening
- 2.3.4 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Beauty Peptide Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Beauty Peptide Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Beauty Peptide Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Beauty Peptide Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Beauty Peptide Production by Manufacturers (2021-2026)
- 3.2 Global Beauty Peptide Production Value by Manufacturers (2021-2026)
- 3.3 Global Beauty Peptide Average Price by Manufacturers (2021-2026)
- 3.4 Global Beauty Peptide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Beauty Peptide Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Beauty Peptide Manufacturers, Product Type & Application
- 3.7 Global Beauty Peptide Manufacturers Established Date
- 3.8 Global Beauty Peptide Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Readline Biotech
- 4.1.1 Readline Biotech Beauty Peptide Company Information
- 4.1.2 Readline Biotech Beauty Peptide Business Overview
- 4.1.3 Readline Biotech Beauty Peptide Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Readline Biotech Product Portfolio
- 4.1.5 Readline Biotech Recent Developments
- 4.2 Pentapharm
- 4.2.1 Pentapharm Beauty Peptide Company Information
- 4.2.2 Pentapharm Beauty Peptide Business Overview
- 4.2.3 Pentapharm Beauty Peptide Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Pentapharm Product Portfolio
- 4.2.5 Pentapharm Recent Developments
- 4.3 Pentapharm
- 4.3.1 Pentapharm Beauty Peptide Company Information
- 4.3.2 Pentapharm Beauty Peptide Business Overview
- 4.3.3 Pentapharm Beauty Peptide Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Pentapharm Product Portfolio
- 4.3.5 Pentapharm Recent Developments
- 4.4 Lipotec
- 4.4.1 Lipotec Beauty Peptide Company Information
- 4.4.2 Lipotec Beauty Peptide Business Overview
- 4.4.3 Lipotec Beauty Peptide Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Lipotec Product Portfolio
- 4.4.5 Lipotec Recent Developments
- 4.5 ISP
- 4.5.1 ISP Beauty Peptide Company Information
- 4.5.2 ISP Beauty Peptide Business Overview
- 4.5.3 ISP Beauty Peptide Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 ISP Product Portfolio
- 4.5.5 ISP Recent Developments
- 4.6 Helix BioMedix
- 4.6.1 Helix BioMedix Beauty Peptide Company Information
- 4.6.2 Helix BioMedix Beauty Peptide Business Overview
- 4.6.3 Helix BioMedix Beauty Peptide Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Helix BioMedix Product Portfolio
- 4.6.5 Helix BioMedix Recent Developments
- 4.7 Evonil
- 4.7.1 Evonil Beauty Peptide Company Information
- 4.7.2 Evonil Beauty Peptide Business Overview
- 4.7.3 Evonil Beauty Peptide Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Evonil Product Portfolio
- 4.7.5 Evonil Recent Developments
- 4.8 Atrium
- 4.8.1 Atrium Beauty Peptide Company Information
- 4.8.2 Atrium Beauty Peptide Business Overview
- 4.8.3 Atrium Beauty Peptide Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Atrium Product Portfolio
- 4.8.5 Atrium Recent Developments
5 Global Beauty Peptide Production by Region
- 5.1 Global Beauty Peptide Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Beauty Peptide Production by Region: 2021-2032
- 5.2.1 Global Beauty Peptide Production by Region: 2021-2026
- 5.2.2 Global Beauty Peptide Production Forecast by Region (2027-2032)
- 5.3 Global Beauty Peptide Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Beauty Peptide Production Value by Region: 2021-2032
- 5.4.1 Global Beauty Peptide Production Value by Region: 2021-2026
- 5.4.2 Global Beauty Peptide Production Value Forecast by Region (2027-2032)
- 5.5 Global Beauty Peptide Market Price Analysis by Region (2021-2026)
- 5.6 Global Beauty Peptide Production and Value, YOY Growth
- 5.6.1 North America Beauty Peptide Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Beauty Peptide Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Beauty Peptide Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Beauty Peptide Production Value Estimates and Forecasts (2021-2032)
6 Global Beauty Peptide Consumption by Region
- 6.1 Global Beauty Peptide Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Beauty Peptide Consumption by Region (2021-2032)
- 6.2.1 Global Beauty Peptide Consumption by Region: 2021-2026
- 6.2.2 Global Beauty Peptide Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Beauty Peptide Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Beauty Peptide Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Beauty Peptide Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Beauty Peptide Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Beauty Peptide Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Beauty Peptide Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Beauty Peptide Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Beauty Peptide Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Beauty Peptide Production by Type (2021-2032)
- 7.1.1 Global Beauty Peptide Production by Type (2021-2032) & (t)
- 7.1.2 Global Beauty Peptide Production Market Share by Type (2021-2032)
- 7.2 Global Beauty Peptide Production Value by Type (2021-2032)
- 7.2.1 Global Beauty Peptide Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Beauty Peptide Production Value Market Share by Type (2021-2032)
- 7.3 Global Beauty Peptide Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Beauty Peptide Production by Application (2021-2032)
- 8.1.1 Global Beauty Peptide Production by Application (2021-2032) & (t)
- 8.1.2 Global Beauty Peptide Production Market Share by Application (2021-2032)
- 8.2 Global Beauty Peptide Production Value by Application (2021-2032)
- 8.2.1 Global Beauty Peptide Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Beauty Peptide Production Value Market Share by Application (2021-2032)
- 8.3 Global Beauty Peptide Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Beauty Peptide Value Chain Analysis
- 9.1.1 Beauty Peptide Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Beauty Peptide Production Mode & Process
- 9.2 Beauty Peptide Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Beauty Peptide Distributors
- 9.2.3 Beauty Peptide Customers
10 Global Beauty Peptide Analyzing Market Dynamics
- 10.1 Beauty Peptide Industry Trends
- 10.2 Beauty Peptide Industry Drivers
- 10.3 Beauty Peptide Industry Opportunities and Challenges
- 10.4 Beauty Peptide Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst